Prostate cancer: open trials in Malaysia

8 open trials have a site in Malaysia. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Sultan Ismail (Site 1081), Johor Bahru · Hospital Kuala Lumpur-Radiotherapy and Oncology (Site 1078), Kuala Lumpur · Sarawak General Hospital-Radiotherapy Unit (Site 1076), Kuching · University Malaya Medical Centre (Site 1077), Lembah Pantai · National Cancer Institute (Site 1079), Putrajaya
Registry updated 2026-11-05
NCT07225946
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Wanita Dan Kanak-Kanak Sabah, Kota Kinabalu · Pantai Hospital Kuala Lumpur, Kuala Lumpur · Hospital Kuala Lumpur, Kuala Lumpur · University Malaya Medical Centre, Kuala Lumpur · Hospital Umum Sarawak, Kuching
Registry updated 2026-11-03
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Sarawak General Hospital (Site 0526), Kuching · Sunway Medical Centre (Site 0529), Petaling Jaya
Registry updated 2026-10-30
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Kuala Lumpur · Petaling Jaya
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Sultan Ismail (Site 0905), Johor Bahru · Hospital Kuala Lumpur-Radiotherapy and Oncology (Site 0903), Kuala Lumpur · Sarawak General Hospital-Radiotherapy Unit (Site 0901), Kuching · University Malaya Medical Centre (Site 0902), Lembah Pantai · National Cancer Institute (Site 0904), Putrajaya
Registry updated 2026-10-20
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
Batu Caves · Kuala Lumpur · Kuala Selangor · Pulau Pinang
Registry updated 2026-10-14
NCT07206056
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Kuching
Registry updated 2026-10-09
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Petaling Jaya · Putrajaya
Registry updated 2026-09-22

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error